NEWS
BioSpace I Why Now is the Best Time to Make the Switch to Pharma and Biotech

Switching your career path will always feel like a daunting undertaking, and there’s no perfect time to do it. And to make matters worse, there will almost always be nay-sayers and moments of difficulty along the way to securing your new job. But that doesn’t mean you shouldn’t try. If you are interested in biopharma […]

Drug Discovery News I Goodbye biopsies, non-invasive diagnostics for fatty liver disease are here

From last night’s happy hour drinks to this morning’s greasy breakfast burrito and ibuprofen, the liver has seen it all. As both factory and filter, the liver is a jack of all trades. It removes harmful toxins from the blood, creates bile to carry away waste, metabolizes drugs, stores iron and other vitamins, and even […]

Drug Discovery & Development I Axogen announces positive topline data from Phase 3 nerve graft study

Focused on developing peripheral nerve regeneration and repair products, Axogen (Nasdaq:AXGN) announced that the Phase 3 RECON study met its primary endpoint in comparing its Avance nerve graft to conduits in digital nerve injuries. The primary endpoint was the return of sensory function based on static two-point discrimination. This test measures the ability to detect that two […]